🕵️ Neurocrine Biosciences Inc ($NBIX)
SEC insider & ownership activity, last 12 months · CIK 914475 · every row links its SEC filing
Over the last 12 months insiders sold $90.3M with no open-market buying against it. Gorman Kevin Charles sold $51.3M through a 10b5-1 trading plan in 2 lots (Aug–May). 2 planned sales are pending, the largest $2.5M (Ingrid Delaet). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 14 sellers, $90.3M (37 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Gorman Kevin Charles | 0 | – | 2 | $51.3M | May 19, 2026 |
| Cooke Julie | 0 | – | 5 | $5.8M | Jun 2, 2026 |
| Kyle Gano | 0 | – | 3 | $4.9M | Jan 16, 2026 |
| Lippoldt Darin | 0 | – | 5 | $4.2M | Jul 9, 2026 |
| Stephen Sherwin | 0 | – | 5 | $4.1M | Jun 5, 2026 |
| Delaet Ingrid | 0 | – | 5 | $3.7M | Jul 10, 2026 |
| Onyia Jude | 0 | – | 2 | $3.5M | Jun 1, 2026 |
| William H. Rastetter | 0 | – | 1 | $2.7M | Nov 5, 2025 |
| Richard F. Pops | 0 | – | 1 | $2.4M | May 15, 2026 |
| Gary A. Lyons | 0 | – | 1 | $2.3M | Dec 3, 2025 |
| George J. Morrow | 0 | – | 1 | $2.2M | Nov 25, 2025 |
| Leslie V. Norwalk | 0 | – | 4 | $1.7M | Jun 4, 2026 |
| Benevich Eric | 0 | – | 1 | $906K | Nov 28, 2025 |
| David Warren Boyer | 0 | – | 1 | $609K | May 26, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Blackrock, Inc. | 12.1% | 13G | Apr 28, 2025 | filing ↗ | |
| JPMorgan Chase & Co. | 6.3% | 13G | Jul 27, 2026 | filing ↗ | |
| Dodge & COX | 5.6% | 13G | May 14, 2025 | filing ↗ | |
| Vanguard Capital Management | 5.2% | 13G | Apr 30, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Ingrid Delaet | $788K | Jul 10, 2026 | filing ↗ |
| Darin Lippoldt | $1.8M | Jul 9, 2026 | filing ↗ |
| Ingrid Delaet | $2.5M | Jul 7, 2026 | filing ↗ |
| Darin Lippoldt | $1.7M | Jun 29, 2026 | filing ↗ |
| Darin Lippoldt | $33K | Jun 26, 2026 | filing ↗ |
| Stephen Sherwin | $4.2M | Jun 5, 2026 | filing ↗ |
| Julie Cooke | $5.9M | Jun 2, 2026 | filing ↗ |
| Jude Onyia | $1.7M | Jun 1, 2026 | filing ↗ |
| Ingrid Delaet | $354K | May 29, 2026 | filing ↗ |
| Jude Onyia | $1.7M | May 27, 2026 | filing ↗ |
| David Warren Boyer | $609K | May 26, 2026 | filing ↗ |
| Kevin Charles Gorman | $38.5M | May 19, 2026 | filing ↗ |
| Richard F Pops | $2.4M | May 15, 2026 | filing ↗ |
| Leslie V. Norwalk | $1.0M | May 12, 2026 | filing ↗ |
| Kyle Gano | $4.9M | Jan 16, 2026 | filing ↗ |
| Leslie V. Norwalk | $1.7M | Dec 15, 2025 | filing ↗ |
| Darin Lippoldt | $681K | Dec 8, 2025 | filing ↗ |
| GARY A Lyons Revocable Living U/A DTD 06/08/2012 | $2.3M | Dec 3, 2025 | filing ↗ |
| Eric Benevich | $905K | Nov 28, 2025 | filing ↗ |
| George Morrow | $2.1M | Nov 25, 2025 | filing ↗ |
| William H. Rastetter | $2.6M | Nov 5, 2025 | filing ↗ |
| Gano Kyle | $43K | Nov 4, 2025 | filing ↗ |
| Kevin Charles Gorman | $13.7M | Aug 7, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | May 27, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 27, 2026 | filing ↗ |
| Material agreement (1.01) | May 14, 2026 | filing ↗ |
| Acquisition or disposition (2.01) | May 14, 2026 | filing ↗ |
| New financial obligation (2.03) | May 14, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 14, 2026 | filing ↗ |
| Earnings (2.02) | May 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 5, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 5, 2026 | filing ↗ |
| Earnings (2.02) | Feb 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 11, 2026 | filing ↗ |
| Officer/director changes (5.02) | Nov 21, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 21, 2025 | filing ↗ |
| Earnings (2.02) | Oct 28, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 28, 2025 | filing ↗ |
| Earnings (2.02) | Jul 30, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 30, 2025 | filing ↗ |